The company cited a combination of 13 in-vitro and in-vivo experiments illustrating the virustatic
, virucidal and prophylactic capacity of the compound as well as product dose and delivery concepts to support the patent claims.
They presented invitro data on the virucidal and virustatic
activitiy of QR-441 on the Avian Flu Virus and its implications.
Virucidal Compound -- QR437: Ongoing pre-clinical research activities include: the completion of a second in vitro experiment to determine virucidal or virustatic
properties against the HIV virus by QR437.
Avian Flu Compound - QR-441: One positive pre-clinical in vitro study on Avian Flu, demonstrating antiviral activity when tested in a virustatic
The Quigley Corporation (Nasdaq: QGLY) reported today that its compound QR-435 has shown virucidal and virustatic
activity against the strain 3B of the Human Immunodeficiency Virus Type 1 (HIV-1) in an in-vitro study.
The test methods include those for common antibiotics, anthelmintics, virustatics
, anti-malarial medicines, tuberculostatics, and other medicines.